Thread by @AimHardy

#DDDD💊

Why I believe @4dpharmaplc are on the cusp of a multi hundred million pound licencing deal for IBD and IBS?

#DDDD💊

Phase 1 data for @4dpharmaplc Blautix's treatment of IBS highlights significant efficacy

-82% Improvement in a reduction of symptoms
-More diverse stable gut bacteria

4dpharmaplc.com/application/fi…

#DDDD💊

Interim Safety Data for Blautix Phase 2 larger study shows excellent safety profile

-Comparable to placebo

We are awaiting efficacy data from the Phase 2 study anticipated this Quarter

4dpharmaplc.com/en/newsroom/pr…

#DDDD💊

If continuation of the efficacy shown in the phase 1 trial (I am increasing encouraged to believe this) this will substantially validate the therapeutic benefit of the drug

A similar company SERES concluded a licence deal with @Nestle with $120m upfront payment

#DDDD💊

This is a strong indication of the need for therapeutics in this area, and @4dpharmaplc are showing strong early indications that Blautix significantly improves patients outcomes